X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26) 26
index medicus (26) 26
child (20) 20
oncology (18) 18
children (17) 17
female (17) 17
hematology (17) 17
childhood (15) 15
male (15) 15
adolescent (14) 14
cancer (13) 13
child, preschool (13) 13
lymphoma (12) 12
lymphomas (12) 12
chemotherapy (10) 10
pediatrics (10) 10
hemic and lymphatic diseases (8) 8
infant (8) 8
prognosis (8) 8
disease-free survival (7) 7
adolescents (6) 6
adult (6) 6
alk (6) 6
leukemia (6) 6
non-hodgkin lymphoma (6) 6
research paper (6) 6
acute-lymphoblastic-leukemia (5) 5
alcl (5) 5
anaplastic large cell lymphoma (5) 5
disease (5) 5
large-cell lymphoma (5) 5
minimal disseminated disease (5) 5
neoplasm, residual (5) 5
non-hodgkin-lymphoma (5) 5
risk (5) 5
treatment outcome (5) 5
tumors (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
blood (4) 4
bone-marrow (4) 4
burkitt lymphoma - genetics (4) 4
expression (4) 4
lymphoma, large-cell, anaplastic - drug therapy (4) 4
lymphoma, large-cell, anaplastic - genetics (4) 4
non-hodgkins-lymphoma (4) 4
patients (4) 4
reverse transcriptase polymerase chain reaction (4) 4
review (4) 4
translocation (4) 4
abridged index medicus (3) 3
acute lymphoblastic-leukemia (3) 3
alk protein (3) 3
analysis (3) 3
anaplastic large-cell lymphoma (3) 3
anaplastic lymphoma kinase (3) 3
antineoplastic agents - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
biomarkers (3) 3
burkitt lymphoma - drug therapy (3) 3
burkitt lymphoma - mortality (3) 3
cell biology (3) 3
cells (3) 3
central nervous system (3) 3
classification (3) 3
crizotinib (3) 3
data processing (3) 3
gene (3) 3
gene expression (3) 3
genetic aspects (3) 3
health aspects (3) 3
lung cancer (3) 3
lymphoblastic lymphoma (3) 3
lymphoma, large-cell, anaplastic - diagnosis (3) 3
lymphoma, large-cell, anaplastic - pathology (3) 3
mutation (3) 3
neoplasms (3) 3
non‐hodgkin lymphoma (3) 3
phosphorylation (3) 3
polymerase chain reaction (3) 3
polymerase-chain-reaction (3) 3
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (3) 3
precursor cell lymphoblastic leukemia-lymphoma - mortality (3) 3
prospective studies (3) 3
protein-tyrosine kinases - genetics (3) 3
protocol (3) 3
receptor protein-tyrosine kinases - metabolism (3) 3
recurrence (3) 3
research (3) 3
risk factors (3) 3
stage (3) 3
translocation, genetic (3) 3
transplantation (3) 3
aluminum compounds (2) 2
animals (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
apoptosis (2) 2
article (2) 2
autoantibodies (2) 2
bone marrow - pathology (2) 2
burkitt lymphoma - pathology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 01/2016, Volume 374, Issue 1, pp. 95 - 96
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2014, Volume 106, Issue 2, pp. djt378 - djt378
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 6/2014, Volume 111, Issue 22, pp. 8185 - 8190
Burkitt lymphoma (BL) is a highly aggressive B-cell non-Hodgkin lymphoma (B-NHL), which originates from germinal center (GC) B cells and harbors translocations... 
Cell growth | MicroRNA | B lymphocytes | B cell lymphoma | Cell lines | Cell cycle | Gene expression regulation | Lymphoma | Globular star clusters | Oncogenes | MAD2 | IN-VITRO | PROTEIN | GENE | PHOSPHORYLATION | MYC | MULTIDISCIPLINARY SCIENCES | GERMINAL CENTER | EXPRESSION PROFILES | CANCER | TUMORIGENESIS | MAP Kinase Signaling System - physiology | Cell Proliferation | Humans | Transcriptome | Lymphoma, B-Cell - genetics | Carcinogenesis | Burkitt Lymphoma - pathology | DNA-Binding Proteins - metabolism | Germinal Center | Cell Transformation, Neoplastic - genetics | Lymphoma, B-Cell - physiopathology | Burkitt Lymphoma - genetics | Gene Expression Regulation, Neoplastic - physiology | Genes, myc - physiology | Cell Cycle Proteins - metabolism | B-Lymphocytes - physiology | Nuclear Proteins - metabolism | RNA Processing, Post-Transcriptional - physiology | Burkitt Lymphoma - physiopathology | Down-Regulation - physiology | Transcription Factors - metabolism | Lymphoma, B-Cell - pathology | Cell Line, Tumor | MicroRNAs - physiology | Adaptor Proteins, Signal Transducing - metabolism | Cell proliferation | Medical research | Genetic research | Medicine, Experimental | Genetic aspects | Lymphomas | B cells | Research | Genetic regulation | Health aspects | Gene expression | Comparative analysis | Chromosomes | Cells | Tumors | Index Medicus | Biological Sciences
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2015, Volume 10, Issue 4, pp. e0121378 - e0121378
ALK inhibitor crizotinib has shown potent antitumor activity in children with refractory Anaplastic Large Cell Lymphoma (ALCL) and the opportunity to include... 
CHRONIC PHASE | LUNG-CANCER | IMATINIB-BASED THERAPY | MUTANTS | DIFFERENTIAL SENSITIVITY | MULTIDISCIPLINARY SCIENCES | CRIZOTINIB | NEUROBLASTOMA | EXPRESSION | ACTIVATING MUTATIONS | CONFER RESISTANCE | Protein-Tyrosine Kinases - metabolism | Humans | Cercopithecus aethiops | Child, Preschool | Drug Resistance, Neoplasm | Infant | Male | Lymphoma, Large-Cell, Anaplastic - enzymology | INDEL Mutation | Protein-Tyrosine Kinases - genetics | Anaplastic Lymphoma Kinase | HEK293 Cells | Protein-Tyrosine Kinases - chemistry | Female | Child | Lymphoma, Large-Cell, Anaplastic - genetics | Pyrazoles - pharmacology | Crizotinib | Protein Structure, Tertiary | Receptor Protein-Tyrosine Kinases - metabolism | Molecular Dynamics Simulation | Point Mutation | Animals | Receptor Protein-Tyrosine Kinases - genetics | Lymphoma, Large-Cell, Anaplastic - drug therapy | Adolescent | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | Mutation | COS Cells | Receptor Protein-Tyrosine Kinases - chemistry | Protein-Tyrosine Kinases - antagonists & inhibitors | Tyrosine | Gene mutations | Analysis | Aluminum compounds | Phenols | Genetic aspects | Non-Hodgkin's lymphomas | Phosphorylation | Lung cancer | Leukemia | ALK protein | Neuroblastoma | Kinases | Cancer therapies | Gene sequencing | Anticancer properties | Proteins | Missense mutation | Children | Protein-tyrosine kinase | Splicing | Computer simulation | Stat3 protein | Simulation analysis | Data processing | Gene expression | Patients | Lymphoma | Refractory materials | Sensitivity | Molecular modelling | Inhibitors | Information processing | Signal processing | Antitumor activity | Lymphomas | Anaplastic large-cell lymphoma | Tumors | Index Medicus
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 11/2015, Volume 62, Issue 11, pp. 1906 - 1913
Journal Article
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, ISSN 2212-4403, 09/2018, Volume 126, Issue 3, pp. e76 - e76
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2011, Volume 29, Issue 13, pp. 1779 - 1784
Journal Article
Blood, ISSN 0006-4971, 06/2011, Volume 117, Issue 26, pp. 7053 - 7062
Journal Article
Cancer Research, ISSN 0008-5472, 04/2012, Volume 72, Issue 8 Supplement, pp. 3034 - 3034
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 08/2015, Volume 62, Issue 8, pp. 1388 - 1394
BackgroundTreatment intensification was considered a suitable strategy to increase the cure rate of lymphoblastic lymphoma (LBL) in children. ProcedureThe... 
treatment | non‐Hodgkin lymphoma | childhood | long‐term outcome | lymphoblastic lymphoma | Non-Hodgkin lymphoma | Treatment | Long-term outcome | Childhood | Lymphoblastic lymphoma | STAGE | NON-HODGKINS-LYMPHOMAS | non-Hodgkin lymphoma | CANCER GROUP | TRANSPLANTATION | TRIAL | CHILDRENS-ONCOLOGY-GROUP | THERAPY | ONCOLOGY | ADOLESCENTS | long-term outcome | PEDIATRICS | RADIOTHERAPY | LEUKEMIA | HEMATOLOGY | Humans | Neoplasm Recurrence, Local | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Hematopoietic Stem Cell Transplantation | Induction Chemotherapy | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Methotrexate - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Disease Progression | Biomarkers, Tumor - blood | Disease-Free Survival | Methotrexate - adverse effects | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Asparaginase - adverse effects | Antineoplastic Agents - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Female | Asparaginase - therapeutic use | Child | Cyclophosphamide | Methotrexate | Hematopoietic stem cells | Asparaginase | Adolescence | Toxicity | Prophylaxis | Central nervous system | Radiation | Stem cell transplantation | Transplantation | Standard error | Malignancy | Males | Subgroups | Risk assessment | Remission | Bioindicators | Children | Adolescents | Health risks | Patients | Survival | Lymphoma | Hemopoiesis | Amplification | Chemotherapy | Medical prognosis | Stem cells | Irradiation | Biomarkers | Lymphomas | Females | Cancer | Index Medicus
Journal Article
Journal Article
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, ISSN 2212-4403, 09/2018, Volume 126, Issue 3, pp. e51 - e52
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, pp. S1162 - S1163
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, pp. S1162 - S1163
Journal Article
Journal of Pediatric Hematology/Oncology, ISSN 1077-4114, 2019, p. 1
Diffuse large B-cell Lymphoma (DLBCL) secondary to a chronic severe Epstein-Barr virus (EBV) infection has not been previously described in a patient with... 
EBV | hematopoietic stem cell transplantation | trisomy 21 | lymphoma
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.